DNA vaccines against anthrax
- 1 October 2004
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 4 (10) , 1661-1667
- https://doi.org/10.1517/14712598.4.10.1661
Abstract
DNA vaccination is vaccination at its simplest. Due to renewed interest in vaccination against anthrax and other biothreat agents, a genetic immunisation approach offers attractive possibilities for rapid, responsive vaccine development. DNA vaccination against anthrax is an active area of research showing promising results at present, which in the short-term and in the future could form the basis for new advances in multi-agent vaccine development. The anthrax ‘model’ constitutes an important experimental system for genetic immunisation technology development.Keywords
This publication has 29 references indexed in Scilit:
- The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteriaNature, 2003
- In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibodyJournal of Medical Microbiology, 2002
- Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United StatesEmerging Infectious Diseases, 2001
- AnthraxAnnual Review of Microbiology, 2001
- The development of new vaccines against Bacillus anthracisJournal of Applied Microbiology, 2001
- Current status of immunization against anthrax: old vaccines may be here to stay for a whileCurrent Opinion in Infectious Diseases, 2000
- AnthraxNew England Journal of Medicine, 1999
- Germination of Bacillus anthracis spores within alveolar macrophagesMolecular Microbiology, 1999
- Clinical Recognition and Management of Patients Exposed to Biological Warfare AgentsJAMA, 1997
- Anthrax vaccines: past, present and futureVaccine, 1991